VANCOUVER, BC, June 10, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional provisional patents that utilize various psilocybin analogs to target clinical depression. MYND Logo (CNW Group/Mynd Life Sciences […]

An awareness campaign — Wyoming: Climb out of the Darkness — for prenatal and postpartum mental health began the first of May and runs through June 26. Now in its third year, the campaign highlights patients suffering, surviving and those lost to mood and anxiety disorders associated with pregnancy and childbirth. As a group, those

People who smoke, suffer from high blood pressure, obesity, or diabetes are not only at greater risk of suffering a stroke, heart attack, or dementia. For them, the risk of being affected by depressive mood or depression also increases. The more risk factors a person has, the more likely this is. Until now, however, it

Whilst there have been some inconsistent results from previous studies, meta-analyses​ and systematic reviews​ indicate that depression may be related to low serum vitamin D concentrations. Previous studies have also indicated an association between depressive symptoms and low-grade inflammatory response​ while a decrease in pro-inflammatory markers has been observed after treatment with anti-depressants and it has been reported​

VANCOUVER, BC, June 10, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional  provisional patents that utilize various psilocybin analogs to target clinical depression. Major Depressive Disorder (“MDD”) is a common and severe illness

DUBLIN–(BUSINESS WIRE)–Jun 10, 2021– The “Major Depressive Disorder – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com‘s offering. This “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical

DUBLIN–(BUSINESS WIRE)–The “Major Depressive Disorder – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It

According to the National Alliance on Mental Illness and the World Health Organization, depression affects 16 million Americans and 322 million people worldwide. Emerging evidence suggests that the COVID-19 pandemic is further exacerbating the prevalence of depression in the general population. With this trajectory, it is evident that more effective strategies are needed for therapeutics

Although estimates vary, patients with cancer (PWC) are at least twice as likely to die by suicide than people who do not have cancer. Moreover, having had psychiatric care prior to one’s diagnosis of cancer may not mitigate this increased risk. Suicide Risk in Cancer The most common cancers worldwide are lung, breast, colorectal, prostate,

To call the current law school admissions cycle a rollercoaster is an understatement. The total number of applicants nationwide is up 17% and the number of people applying for fall 2021 with Law School Admission Test Scores of 170 or higher is up 65%, according to data from the Law School Admission Council. All of